0000706698 2026-01-01 2026-06-30 0000706698 2026-06-30 0000706698 2025-06-30 0000706698 2026-08-11 0000706698 2025-12-31 0000706698 2026-04-01 2026-06-30 0000706698 2025-04-01 2025-06-30 0000706698 2025-01-01 2025-06-30 0000706698 2024-12-31 0000706698 us-gaap:CommonStockMember 2025-12-31 0000706698 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0000706698 us-gaap:ComprehensiveIncomeMember 2025-12-31 0000706698 us-gaap:RetainedEarningsMember 2025-12-31 0000706698 2026-01-01 2026-03-31 0000706698 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0000706698 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0000706698 us-gaap:ComprehensiveIncomeMember 2026-01-01 2026-03-31 0000706698 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0000706698 2026-03-31 0000706698 us-gaap:CommonStockMember 2026-03-31 0000706698 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0000706698 us-gaap:ComprehensiveIncomeMember 2026-03-31 0000706698 us-gaap:RetainedEarningsMember 2026-03-31 0000706698 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0000706698 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0000706698 us-gaap:ComprehensiveIncomeMember 2026-04-01 2026-06-30 0000706698 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0000706698 us-gaap:CommonStockMember 2026-06-30 0000706698 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0000706698 us-gaap:ComprehensiveIncomeMember 2026-06-30 0000706698 us-gaap:RetainedEarningsMember 2026-06-30 0000706698 us-gaap:CommonStockMember 2024-12-31 0000706698 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000706698 us-gaap:ComprehensiveIncomeMember 2024-12-31 0000706698 us-gaap:RetainedEarningsMember 2024-12-31 0000706698 2025-01-01 2025-03-31 0000706698 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000706698 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000706698 us-gaap:ComprehensiveIncomeMember 2025-01-01 2025-03-31 0000706698 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000706698 2025-03-31 0000706698 us-gaap:CommonStockMember 2025-03-31 0000706698 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000706698 us-gaap:ComprehensiveIncomeMember 2025-03-31 0000706698 us-gaap:RetainedEarningsMember 2025-03-31 0000706698 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000706698 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000706698 us-gaap:ComprehensiveIncomeMember 2025-04-01 2025-06-30 0000706698 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000706698 us-gaap:CommonStockMember 2025-06-30 0000706698 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000706698 us-gaap:ComprehensiveIncomeMember 2025-06-30 0000706698 us-gaap:RetainedEarningsMember 2025-06-30 0000706698 fil:DomesticUsMember 2026-01-01 2026-06-30 0000706698 fil:OutsideUsMember 2026-01-01 2026-06-30 0000706698 fil:ObstetricsMember 2026-01-01 2026-06-30 0000706698 fil:ObstetricsMember fil:DomesticUsMember 2026-04-01 2026-06-30 0000706698 fil:ObstetricsMember fil:OutsideUsMember 2026-04-01 2026-06-30 0000706698 fil:ObstetricsMember 2026-04-01 2026-06-30 0000706698 fil:GynecologyElectrosurgeryUrologyMember 2026-01-01 2026-06-30 0000706698 fil:GynecologyElectrosurgeryUrologyMember fil:DomesticUsMember 2026-04-01 2026-06-30 0000706698 fil:GynecologyElectrosurgeryUrologyMember fil:OutsideUsMember 2026-04-01 2026-06-30 0000706698 fil:GynecologyElectrosurgeryUrologyMember 2026-04-01 2026-06-30 0000706698 fil:NeonatalMember 2026-01-01 2026-06-30 0000706698 fil:NeonatalMember fil:DomesticUsMember 2026-04-01 2026-06-30 0000706698 fil:NeonatalMember fil:OutsideUsMember 2026-04-01 2026-06-30 0000706698 fil:NeonatalMember 2026-04-01 2026-06-30 0000706698 fil:BloodPressureMonitoringAndAccessoriesMember 2026-01-01 2026-06-30 0000706698 fil:BloodPressureMonitoringAndAccessoriesMember fil:DomesticUsMember 2026-04-01 2026-06-30 0000706698 fil:BloodPressureMonitoringAndAccessoriesMember fil:OutsideUsMember 2026-04-01 2026-06-30 0000706698 fil:BloodPressureMonitoringAndAccessoriesMember 2026-04-01 2026-06-30 0000706698 fil:DomesticUsMember 2026-04-01 2026-06-30 0000706698 fil:OutsideUsMember 2026-04-01 2026-06-30 0000706698 fil:ObstetricsMember fil:DomesticUsMember 2026-01-01 2026-06-30 0000706698 fil:ObstetricsMember fil:OutsideUsMember 2026-01-01 2026-06-30 0000706698 fil:GynecologyElectrosurgeryUrologyMember fil:DomesticUsMember 2026-01-01 2026-06-30 0000706698 fil:GynecologyElectrosurgeryUrologyMember fil:OutsideUsMember 2026-01-01 2026-06-30 0000706698 fil:NeonatalMember fil:DomesticUsMember 2026-01-01 2026-06-30 0000706698 fil:NeonatalMember fil:OutsideUsMember 2026-01-01 2026-06-30 0000706698 fil:BloodPressureMonitoringAndAccessoriesMember fil:DomesticUsMember 2026-01-01 2026-06-30 0000706698 fil:BloodPressureMonitoringAndAccessoriesMember fil:OutsideUsMember 2026-01-01 2026-06-30 0000706698 fil:SingleOperatingSegmentMember 2026-01-01 2026-06-30 0000706698 fil:SingleOperatingSegmentMember 2025-01-01 2025-06-30 iso4217:USD shares iso4217:USD shares pure 0000706698 --12-31 Yes false 2026 Q2 10-Q true 2026-06-30 false 001-12575 UTAH MEDICAL PRODUCTS INC UT 87-0342734 7043 South 300 West Midvale UT 84047 801 566-1200 Common stock, $0.01 par value UTMD NASDAQ Yes Non-accelerated Filer true false false 3183818

87528000

85756000

3565000

3522000

9003000

7935000

543000

529000

100639000

97742000

9631000

9908000

13956000

14052000

55459000

55941000

55113000

55101000

346000

840000

124572000

122542000

876000

911000

1194000

1687000

2070000

2598000

114000

195000

225000

274000

337000

2539000

3274000

0.01

50000000

3183000

3186000

32000

-9953000

-9416000

131954000

128652000

122033000

119268000

124572000

122542000

8529000

9953000

17252000

19663000

3771000

4358000

7212000

8530000

4758000

5595000

10040000

11133000

1955000

2264000

4517000

4495000

154000

135000

308000

289000

2109000

2399000

4825000

4784000

2649000

3196000

5215000

6349000

637000

640000

1254000

1345000

3286000

3836000

6469000

7694000

600000

788000

1179000

1605000

2686000

3048000

5290000

6089000

0.84

0.94

1.66

1.86

0.84

0.94

1.66

1.86

3184000

3246000

3184000

3278000

3184000

3246000

3184000

3278000

-34000

1828000

-536000

2546000

2652000

4876000

4754000

8635000

5290000

6089000

421000

405000

478000

1048000

-12000

-7000

30000

26000

-178000

-360000

192000

168000

56000

-409000

1130000

-908000

22000

-145000

-34000

37000

-487000

-1531000

-798000

1248000

4492000

7337000

264000

235000

-264000

-235000

206000

6708000

1976000

2018000

-2182000

-8726000

-274000

827000

1772000

-797000

85756000

82976000

87528000

82179000

1660000

2327000

3186000

32000

-9416000

128652000

119268000

120000

-2000

-120000

-8000

-128000

-503000

987000

2604000

3184000

32000

-9919000

130260000

120373000

72000

-1000

-72000

-5000

-77000

-34000

987000

2686000

3183000

32000

-9952000

131954000

122034000

3335000

36000

593000

-11908000

129302000

117427000

0 0 0 0 0 0

82000

-54000

-1000

-82000

-3138000

-3221000

718000

1001000

3041000

3281000

33000

-11190000

128204000

117047000

0 0 0 0 0 0

86000

-65000

-1000

-86000

-3402000

-3488000

1828000

988000

3048000

3216000

32000

-9362000

128862000

117533000

<kbd style="position:absolute;font:10pt Times New Roman;margin-left:0pt">(1)</kbd><kbd style="margin-left:19.8pt"></kbd>The unaudited financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and note disclosures required by accounting principles generally accepted in the United States. These statements should be read in conjunction with the financial statements and notes included in the Utah Medical Products, Inc. ("UTMD" or "the Company") annual report on Form 10-K for the year ended December 31, 2025. In the opinion of management, the accompanying financial statements include all adjustments (consisting only of normal recurring adjustments) necessary to summarize fairly the Company's financial position and results of operations. Currency amounts are in thousands except per-share amounts and where noted.

(2) Recent Accounting Standards. In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03. In September 2025, the FASB issued ASU 2025-06, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software”. This ASU clarifies and modernizes the accounting for costs related to internal-use software by removing references to prescriptive and sequential software development states and clarifies the threshold entities apply to begin capitalizing costs. Additionally, this ASU specifies that the disclosures in Subtopic 360-10, Property, Plant and Equipment - Overall, are required for all capitalized internal-use software costs, regardless of how those costs are presented in the financial statements. This ASU is effective for fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is evaluating the impact of adopting ASU 2025-06.

<kbd style="position:absolute;font:10pt Times New Roman;margin-left:0pt">(3)</kbd><kbd style="margin-left:19.8pt"></kbd>Inventories at June 30, 2026 and December 31, 2025 consisted of the following: <table style="border-collapse:collapse;width:469.3pt"><tr style="height:7.2pt"><td style="width:225pt" valign="bottom"> </td><td style="width:12.95pt" valign="bottom"> </td><td style="width:11.95pt" valign="bottom"> </td><td colspan="2" style="width:95.15pt" valign="middle">June 30, </td><td style="width:11.8pt" valign="middle"> </td><td colspan="2" style="width:112.45pt" valign="middle">December 31, </td></tr> <tr style="height:7.2pt"><td style="width:225pt" valign="bottom"></td><td style="width:12.95pt" valign="bottom"> </td><td style="width:11.95pt" valign="bottom"> </td><td colspan="2" style="width:95.15pt;border-bottom:0.5pt solid #000000" valign="middle">2026 </td><td style="width:11.8pt" valign="middle"> </td><td colspan="2" style="width:112.45pt;border-bottom:0.5pt solid #000000" valign="middle">2025 </td></tr> <tr style="height:7.2pt"><td style="background-color:#CCEEFF;width:225pt" valign="middle">Finished goods </td><td style="background-color:#CCEEFF;width:12.95pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:11.95pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:15.85pt" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:79.3pt" valign="bottom">1,898 </td><td style="background-color:#CCEEFF;width:11.8pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:15.85pt" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:96.6pt" valign="bottom">1,223 </td></tr> <tr style="height:7.2pt"><td style="width:225pt" valign="middle">Work-in-process </td><td style="width:12.95pt" valign="bottom"> </td><td style="width:11.95pt" valign="bottom"> </td><td colspan="2" style="width:95.15pt" valign="bottom">1,604 </td><td style="width:11.8pt" valign="bottom"> </td><td colspan="2" style="width:112.45pt" valign="bottom">1,627 </td></tr> <tr style="height:7.2pt"><td style="background-color:#CCEEFF;width:225pt" valign="middle">Raw materials </td><td style="background-color:#CCEEFF;width:12.95pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:11.95pt" valign="bottom"> </td><td colspan="2" style="background-color:#CCEEFF;width:95.15pt" valign="bottom">5,501 </td><td style="background-color:#CCEEFF;width:11.8pt" valign="bottom"> </td><td colspan="2" style="background-color:#CCEEFF;width:112.45pt" valign="bottom">5,085 </td></tr> <tr style="height:7.2pt"><td style="width:225pt" valign="middle">Total </td><td style="width:12.95pt" valign="bottom"> </td><td style="width:11.95pt" valign="bottom"> </td><td style="width:15.85pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:79.3pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">9,003 </td><td style="width:11.8pt" valign="bottom"> </td><td style="width:15.85pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:96.6pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">7,935 </td></tr> </table>

<table style="border-collapse:collapse;width:469.3pt"><tr style="height:7.2pt"><td style="width:225pt" valign="bottom"> </td><td style="width:12.95pt" valign="bottom"> </td><td style="width:11.95pt" valign="bottom"> </td><td colspan="2" style="width:95.15pt" valign="middle">June 30, </td><td style="width:11.8pt" valign="middle"> </td><td colspan="2" style="width:112.45pt" valign="middle">December 31, </td></tr> <tr style="height:7.2pt"><td style="width:225pt" valign="bottom"></td><td style="width:12.95pt" valign="bottom"> </td><td style="width:11.95pt" valign="bottom"> </td><td colspan="2" style="width:95.15pt;border-bottom:0.5pt solid #000000" valign="middle">2026 </td><td style="width:11.8pt" valign="middle"> </td><td colspan="2" style="width:112.45pt;border-bottom:0.5pt solid #000000" valign="middle">2025 </td></tr> <tr style="height:7.2pt"><td style="background-color:#CCEEFF;width:225pt" valign="middle">Finished goods </td><td style="background-color:#CCEEFF;width:12.95pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:11.95pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:15.85pt" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:79.3pt" valign="bottom">1,898 </td><td style="background-color:#CCEEFF;width:11.8pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:15.85pt" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:96.6pt" valign="bottom">1,223 </td></tr> <tr style="height:7.2pt"><td style="width:225pt" valign="middle">Work-in-process </td><td style="width:12.95pt" valign="bottom"> </td><td style="width:11.95pt" valign="bottom"> </td><td colspan="2" style="width:95.15pt" valign="bottom">1,604 </td><td style="width:11.8pt" valign="bottom"> </td><td colspan="2" style="width:112.45pt" valign="bottom">1,627 </td></tr> <tr style="height:7.2pt"><td style="background-color:#CCEEFF;width:225pt" valign="middle">Raw materials </td><td style="background-color:#CCEEFF;width:12.95pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:11.95pt" valign="bottom"> </td><td colspan="2" style="background-color:#CCEEFF;width:95.15pt" valign="bottom">5,501 </td><td style="background-color:#CCEEFF;width:11.8pt" valign="bottom"> </td><td colspan="2" style="background-color:#CCEEFF;width:112.45pt" valign="bottom">5,085 </td></tr> <tr style="height:7.2pt"><td style="width:225pt" valign="middle">Total </td><td style="width:12.95pt" valign="bottom"> </td><td style="width:11.95pt" valign="bottom"> </td><td style="width:15.85pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:79.3pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">9,003 </td><td style="width:11.8pt" valign="bottom"> </td><td style="width:15.85pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">$ </td><td style="width:96.6pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="bottom">7,935 </td></tr> </table>

1898000

1223000

1604000

1627000

5501000

5085000

9003000

7935000

<kbd style="position:absolute;font:10pt Times New Roman;margin-left:0pt">(4)</kbd><kbd style="margin-left:18pt"></kbd>Stock-Based Compensation. At June 30, 2026, the Company has stock-based employee compensation plans which authorize the grant of stock options to eligible employees and directors. The Company accounts for stock compensation under FASB Accounting Standards Codification (“ASC”) 718, Compensation - Stock Compensation. This statement requires the Company to recognize compensation cost based on the grant date fair value of options granted to employees and directors. In the six months ended June 30, 2026 and June 30, 2025, the Company recognized $192 and $168, respectively, in stock-based compensation cost.

192000 168000

<kbd style="position:absolute;font:10pt Times New Roman;margin-left:0pt">(5) </kbd><kbd style="margin-left:18pt"></kbd>Warranty Reserve. The Company’s published warranty is: “UTMD warrants its products to conform in all material respects to all published product specifications in effect on the date of shipment, and to be free from defects in material and workmanship for a period of thirty (30) days for supplies, or twenty-four (24) months for equipment, from date of shipment. During the warranty period UTMD shall, at its option, replace any products shown to UTMD's reasonable satisfaction to be defective at no expense to the Purchaser or refund the purchase price.” UTMD maintains a warranty reserve to provide for estimated costs which are likely to occur. The amount of this reserve is adjusted, as required, to reflect its actual experience. Based on its analysis of historical warranty claims and its estimate that existing warranty obligations were immaterial, no warranty reserve was made at December 31, 2025 or June 30, 2026.

(6) 2Q 2026 global revenues (USD) by product category: <table style="border-collapse:collapse;border-bottom:0.5pt solid #000000"><tr><td style="width:180pt" valign="top"></td><td style="width:23.05pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:58.3pt;border-bottom:0.5pt solid #000000" valign="top">Domestic </td><td style="width:18.75pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:62.6pt;border-bottom:0.5pt solid #000000" valign="top">Outside US </td><td style="width:19.5pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:54pt;border-bottom:0.5pt solid #000000" valign="top">Total </td></tr> <tr><td style="background-color:#CCEEFF;width:180pt" valign="top">Obstetrics </td><td style="background-color:#CCEEFF;width:23.05pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:58.3pt;border-top:0.5pt solid #000000" valign="top">863 </td><td style="background-color:#CCEEFF;width:18.75pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:62.6pt;border-top:0.5pt solid #000000" valign="top">203 </td><td style="background-color:#CCEEFF;width:19.5pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:54pt;border-top:0.5pt solid #000000" valign="top">1,066 </td></tr> <tr><td style="width:180pt" valign="top">Gynecology/Electrosurgery/Urology </td><td style="width:23.05pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:58.3pt" valign="top">2,061 </td><td style="width:18.75pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:62.6pt" valign="top">2,219 </td><td style="width:19.5pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:54pt" valign="top">4,280 </td></tr> <tr><td style="background-color:#CCEEFF;width:180pt" valign="top">Neonatal </td><td style="background-color:#CCEEFF;width:23.05pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top"> </td><td style="background-color:#CCEEFF;width:58.3pt" valign="top">1,377 </td><td style="background-color:#CCEEFF;width:18.75pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top"> </td><td style="background-color:#CCEEFF;width:62.6pt" valign="top">542 </td><td style="background-color:#CCEEFF;width:19.5pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top"> </td><td style="background-color:#CCEEFF;width:54pt" valign="top">1,919 </td></tr> <tr><td style="width:180pt" valign="top">Blood Pressure Monitoring and Accessories </td><td style="width:23.05pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:58.3pt;border-bottom:0.5pt solid #000000" valign="top">865 </td><td style="width:18.75pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:62.6pt;border-bottom:0.5pt solid #000000" valign="top">399 </td><td style="width:19.5pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:54pt;border-bottom:0.5pt solid #000000" valign="top">1,264 </td></tr> <tr><td style="background-color:#CCEEFF;width:180pt" valign="top">Total </td><td style="background-color:#CCEEFF;width:23.05pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:58.3pt;border-top:0.5pt solid #000000" valign="top">5,166 </td><td style="background-color:#CCEEFF;width:18.75pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:62.6pt;border-top:0.5pt solid #000000" valign="top">3,363 </td><td style="background-color:#CCEEFF;width:19.5pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:54pt;border-top:0.5pt solid #000000" valign="top">8,529 </td></tr> </table> Global 1H 2026 revenues (USD) by product category: <table style="border-collapse:collapse;border-bottom:0.5pt solid #000000"><tr style="height:13.95pt"><td style="width:183.7pt" valign="top"></td><td style="width:23.55pt" valign="top"> </td><td style="width:8.8pt" valign="top"> </td><td style="width:55.1pt;border-bottom:0.5pt solid #000000" valign="top">Domestic </td><td style="width:16.85pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:61.6pt;border-bottom:0.5pt solid #000000" valign="top">Outside US </td><td style="width:19.4pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:58.45pt;border-bottom:0.5pt solid #000000" valign="top">Total </td></tr> <tr style="height:13.05pt"><td style="background-color:#CCEEFF;width:183.7pt" valign="top">Obstetrics </td><td style="background-color:#CCEEFF;width:23.55pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.8pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:55.1pt;border-top:0.5pt solid #000000" valign="top">1,617 </td><td style="background-color:#CCEEFF;width:16.85pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:61.6pt;border-top:0.5pt solid #000000" valign="top">355 </td><td style="background-color:#CCEEFF;width:19.4pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:58.45pt;border-top:0.5pt solid #000000" valign="top">1,972 </td></tr> <tr style="height:13.05pt"><td style="width:183.7pt" valign="top">Gynecology/Electrosurgery/Urology </td><td style="width:23.55pt" valign="top"> </td><td style="width:8.8pt" valign="top"> </td><td style="width:55.1pt" valign="top">4,755 </td><td style="width:16.85pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:61.6pt" valign="top">4,753 </td><td style="width:19.4pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:58.45pt" valign="top">9,508 </td></tr> <tr style="height:13.95pt"><td style="background-color:#CCEEFF;width:183.7pt" valign="top">Neonatal </td><td style="background-color:#CCEEFF;width:23.55pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.8pt" valign="top"> </td><td style="background-color:#CCEEFF;width:55.1pt" valign="top">2,715 </td><td style="background-color:#CCEEFF;width:16.85pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top"> </td><td style="background-color:#CCEEFF;width:61.6pt" valign="top">774 </td><td style="background-color:#CCEEFF;width:19.4pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top"> </td><td style="background-color:#CCEEFF;width:58.45pt" valign="top">3,489 </td></tr> <tr style="height:13.05pt"><td style="width:183.7pt" valign="top">Blood Pressure Monitoring and Accessories </td><td style="width:23.55pt" valign="top"> </td><td style="width:8.8pt" valign="top"> </td><td style="width:55.1pt;border-bottom:0.5pt solid #000000" valign="top">1,640 </td><td style="width:16.85pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:61.6pt;border-bottom:0.5pt solid #000000" valign="top">643 </td><td style="width:19.4pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:58.45pt;border-bottom:0.5pt solid #000000" valign="top">2,283 </td></tr> <tr style="height:13.95pt"><td style="background-color:#CCEEFF;width:183.7pt" valign="top">Total </td><td style="background-color:#CCEEFF;width:23.55pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.8pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:55.1pt;border-top:0.5pt solid #000000" valign="top">10,727 </td><td style="background-color:#CCEEFF;width:16.85pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:61.6pt;border-top:0.5pt solid #000000" valign="top">6,525 </td><td style="background-color:#CCEEFF;width:19.4pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:58.45pt;border-top:0.5pt solid #000000" valign="top">17,252 </td></tr> </table>

<table style="border-collapse:collapse;border-bottom:0.5pt solid #000000"><tr><td style="width:180pt" valign="top"></td><td style="width:23.05pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:58.3pt;border-bottom:0.5pt solid #000000" valign="top">Domestic </td><td style="width:18.75pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:62.6pt;border-bottom:0.5pt solid #000000" valign="top">Outside US </td><td style="width:19.5pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:54pt;border-bottom:0.5pt solid #000000" valign="top">Total </td></tr> <tr><td style="background-color:#CCEEFF;width:180pt" valign="top">Obstetrics </td><td style="background-color:#CCEEFF;width:23.05pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:58.3pt;border-top:0.5pt solid #000000" valign="top">863 </td><td style="background-color:#CCEEFF;width:18.75pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:62.6pt;border-top:0.5pt solid #000000" valign="top">203 </td><td style="background-color:#CCEEFF;width:19.5pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:54pt;border-top:0.5pt solid #000000" valign="top">1,066 </td></tr> <tr><td style="width:180pt" valign="top">Gynecology/Electrosurgery/Urology </td><td style="width:23.05pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:58.3pt" valign="top">2,061 </td><td style="width:18.75pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:62.6pt" valign="top">2,219 </td><td style="width:19.5pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:54pt" valign="top">4,280 </td></tr> <tr><td style="background-color:#CCEEFF;width:180pt" valign="top">Neonatal </td><td style="background-color:#CCEEFF;width:23.05pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top"> </td><td style="background-color:#CCEEFF;width:58.3pt" valign="top">1,377 </td><td style="background-color:#CCEEFF;width:18.75pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top"> </td><td style="background-color:#CCEEFF;width:62.6pt" valign="top">542 </td><td style="background-color:#CCEEFF;width:19.5pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top"> </td><td style="background-color:#CCEEFF;width:54pt" valign="top">1,919 </td></tr> <tr><td style="width:180pt" valign="top">Blood Pressure Monitoring and Accessories </td><td style="width:23.05pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:58.3pt;border-bottom:0.5pt solid #000000" valign="top">865 </td><td style="width:18.75pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:62.6pt;border-bottom:0.5pt solid #000000" valign="top">399 </td><td style="width:19.5pt" valign="top"> </td><td style="width:8.65pt" valign="top"> </td><td style="width:54pt;border-bottom:0.5pt solid #000000" valign="top">1,264 </td></tr> <tr><td style="background-color:#CCEEFF;width:180pt" valign="top">Total </td><td style="background-color:#CCEEFF;width:23.05pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:58.3pt;border-top:0.5pt solid #000000" valign="top">5,166 </td><td style="background-color:#CCEEFF;width:18.75pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:62.6pt;border-top:0.5pt solid #000000" valign="top">3,363 </td><td style="background-color:#CCEEFF;width:19.5pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.65pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:54pt;border-top:0.5pt solid #000000" valign="top">8,529 </td></tr> </table> Global 1H 2026 revenues (USD) by product category: <table style="border-collapse:collapse;border-bottom:0.5pt solid #000000"><tr style="height:13.95pt"><td style="width:183.7pt" valign="top"></td><td style="width:23.55pt" valign="top"> </td><td style="width:8.8pt" valign="top"> </td><td style="width:55.1pt;border-bottom:0.5pt solid #000000" valign="top">Domestic </td><td style="width:16.85pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:61.6pt;border-bottom:0.5pt solid #000000" valign="top">Outside US </td><td style="width:19.4pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:58.45pt;border-bottom:0.5pt solid #000000" valign="top">Total </td></tr> <tr style="height:13.05pt"><td style="background-color:#CCEEFF;width:183.7pt" valign="top">Obstetrics </td><td style="background-color:#CCEEFF;width:23.55pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.8pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:55.1pt;border-top:0.5pt solid #000000" valign="top">1,617 </td><td style="background-color:#CCEEFF;width:16.85pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:61.6pt;border-top:0.5pt solid #000000" valign="top">355 </td><td style="background-color:#CCEEFF;width:19.4pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:58.45pt;border-top:0.5pt solid #000000" valign="top">1,972 </td></tr> <tr style="height:13.05pt"><td style="width:183.7pt" valign="top">Gynecology/Electrosurgery/Urology </td><td style="width:23.55pt" valign="top"> </td><td style="width:8.8pt" valign="top"> </td><td style="width:55.1pt" valign="top">4,755 </td><td style="width:16.85pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:61.6pt" valign="top">4,753 </td><td style="width:19.4pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:58.45pt" valign="top">9,508 </td></tr> <tr style="height:13.95pt"><td style="background-color:#CCEEFF;width:183.7pt" valign="top">Neonatal </td><td style="background-color:#CCEEFF;width:23.55pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.8pt" valign="top"> </td><td style="background-color:#CCEEFF;width:55.1pt" valign="top">2,715 </td><td style="background-color:#CCEEFF;width:16.85pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top"> </td><td style="background-color:#CCEEFF;width:61.6pt" valign="top">774 </td><td style="background-color:#CCEEFF;width:19.4pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top"> </td><td style="background-color:#CCEEFF;width:58.45pt" valign="top">3,489 </td></tr> <tr style="height:13.05pt"><td style="width:183.7pt" valign="top">Blood Pressure Monitoring and Accessories </td><td style="width:23.55pt" valign="top"> </td><td style="width:8.8pt" valign="top"> </td><td style="width:55.1pt;border-bottom:0.5pt solid #000000" valign="top">1,640 </td><td style="width:16.85pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:61.6pt;border-bottom:0.5pt solid #000000" valign="top">643 </td><td style="width:19.4pt" valign="top"> </td><td style="width:9pt" valign="top"> </td><td style="width:58.45pt;border-bottom:0.5pt solid #000000" valign="top">2,283 </td></tr> <tr style="height:13.95pt"><td style="background-color:#CCEEFF;width:183.7pt" valign="top">Total </td><td style="background-color:#CCEEFF;width:23.55pt" valign="top"> </td><td style="background-color:#CCEEFF;width:8.8pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:55.1pt;border-top:0.5pt solid #000000" valign="top">10,727 </td><td style="background-color:#CCEEFF;width:16.85pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:61.6pt;border-top:0.5pt solid #000000" valign="top">6,525 </td><td style="background-color:#CCEEFF;width:19.4pt" valign="top"> </td><td style="background-color:#CCEEFF;width:9pt" valign="top">$ </td><td style="background-color:#CCEEFF;width:58.45pt;border-top:0.5pt solid #000000" valign="top">17,252 </td></tr> </table>

863000

203000

1066000

2061000

2219000

4280000

1377000

542000

1919000

865000

399000

1264000

5166000

3363000

8529000

1617000

355000

1972000

4755000

4753000

9508000

2715000

774000

3489000

1640000

643000

2283000

10727000

6525000

17252000

7) Earnings Per Share. Basic earnings per share were calculated by dividing net income attributable to the common stockholders of the company by the weighted average number of common shares outstanding during each applicable period. Diluted earnings per share were calculated by assuming the exercise of stock options at the closing price of stock at the end of 2Q 2026 and 2025, as applicable. The following table reconciles the numerator and the denominator used to calculate basic and diluted earnings per share: <table style="border-collapse:collapse;margin-left:5.4pt;border:0.5pt solid #000000"><tr style="height:12.5pt"><td style="width:133.85pt;border-top:0.5pt solid #000000" valign="top">(in thousands) </td><td colspan="3" style="width:139.5pt;border-top:0.5pt solid #000000" valign="top">Three months ended </td><td style="width:13.5pt;border-top:0.5pt solid #000000" valign="top"> </td><td colspan="3" style="width:141.55pt;border-top:0.5pt solid #000000" valign="top">Six months ended </td></tr> <tr style="height:12.5pt"><td style="width:133.85pt" valign="top"> </td><td colspan="3" style="width:139.5pt" valign="top">June 30, </td><td style="width:13.5pt" valign="top"> </td><td colspan="3" style="width:141.55pt" valign="top">June 30, </td></tr> <tr style="height:12.5pt"><td style="width:133.85pt" valign="top"></td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">2026 </td><td style="width:13.5pt" valign="top"> </td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">2025 </td><td style="width:13.5pt" valign="top"> </td><td style="width:60.55pt;border-bottom:0.5pt solid #000000" valign="middle">2026 </td><td style="width:13.5pt" valign="top"> </td><td style="width:67.5pt;border-bottom:0.5pt solid #000000" valign="middle">2025 </td></tr> <tr style="height:12.5pt"><td style="background-color:#D3F0FE;width:133.85pt" valign="top">Numerator </td><td style="background-color:#D3F0FE;width:63pt;border-top:0.5pt solid #000000" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt;border-top:0.5pt solid #000000" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:60.55pt;border-top:0.5pt solid #000000" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:67.5pt;border-top:0.5pt solid #000000" valign="top"> </td></tr> <tr style="height:11.2pt"><td style="width:133.85pt" valign="top">Net income </td><td style="width:63pt" valign="middle">2,686 </td><td style="width:13.5pt" valign="top"> </td><td style="width:63pt" valign="middle">3,048 </td><td style="width:13.5pt" valign="top"> </td><td style="width:60.55pt" valign="middle">5,290 </td><td style="width:13.5pt" valign="top"> </td><td style="width:67.5pt" valign="middle">6,089 </td></tr> <tr style="height:12.5pt"><td style="background-color:#D3F0FE;width:133.85pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:60.55pt" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:67.5pt" valign="top"> </td></tr> <tr style="height:12pt"><td style="width:133.85pt" valign="top">Denominator </td><td style="width:63pt" valign="top"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:63pt" valign="top"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:60.55pt" valign="top"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:67.5pt" valign="top"> </td></tr> <tr style="height:12.5pt"><td style="background-color:#D3F0FE;width:133.85pt" valign="top">Weighted average shares, basic </td><td style="background-color:#D3F0FE;width:63pt" valign="middle">3,184 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt" valign="middle">3,246 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:60.55pt" valign="middle">3,184 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:67.5pt" valign="middle">3,278 </td></tr> <tr style="height:12.5pt"><td style="width:133.85pt" valign="top">Dilutive effect of stock options </td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">- </td><td style="width:13.5pt" valign="top"> </td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">- </td><td style="width:13.5pt" valign="top"> </td><td style="width:60.55pt;border-bottom:0.5pt solid #000000" valign="middle">- </td><td style="width:13.5pt" valign="top"> </td><td style="width:67.5pt;border-bottom:0.5pt solid #000000" valign="middle">- </td></tr> <tr style="height:12.5pt"><td style="background-color:#D3F0FE;width:133.85pt" valign="top">Diluted shares </td><td style="background-color:#D3F0FE;width:63pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle">3,184 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle">3,246 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:60.55pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle">3,184 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:67.5pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle">3,278 </td></tr> <tr style="height:12.5pt"><td style="width:133.85pt" valign="top"> </td><td style="width:63pt;border-top:3px double #000000" valign="middle"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:63pt;border-top:3px double #000000" valign="middle"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:60.55pt;border-top:3px double #000000" valign="middle"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:67.5pt;border-top:3px double #000000" valign="middle"> </td></tr> <tr style="height:12.5pt"><td style="background-color:#D3F0FE;width:133.85pt" valign="top">Earnings per share, basic </td><td style="background-color:#D3F0FE;width:63pt" valign="middle">0.84 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt" valign="middle">0.94 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:60.55pt" valign="middle">1.66 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:67.5pt" valign="middle">1.86 </td></tr> <tr style="height:12.5pt"><td style="width:133.85pt;border-bottom:0.5pt solid #000000" valign="top">Earnings per share, diluted </td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">0.84 </td><td style="width:13.5pt;border-bottom:0.5pt solid #000000" valign="top"> </td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">0.94 </td><td style="width:13.5pt;border-bottom:0.5pt solid #000000" valign="top"> </td><td style="width:60.55pt;border-bottom:0.5pt solid #000000" valign="middle">1.66 </td><td style="width:13.5pt;border-bottom:0.5pt solid #000000" valign="top"> </td><td style="width:67.5pt;border-bottom:0.5pt solid #000000" valign="middle">1.86 </td></tr> </table>

<table style="border-collapse:collapse;margin-left:5.4pt;border:0.5pt solid #000000"><tr style="height:12.5pt"><td style="width:133.85pt;border-top:0.5pt solid #000000" valign="top">(in thousands) </td><td colspan="3" style="width:139.5pt;border-top:0.5pt solid #000000" valign="top">Three months ended </td><td style="width:13.5pt;border-top:0.5pt solid #000000" valign="top"> </td><td colspan="3" style="width:141.55pt;border-top:0.5pt solid #000000" valign="top">Six months ended </td></tr> <tr style="height:12.5pt"><td style="width:133.85pt" valign="top"> </td><td colspan="3" style="width:139.5pt" valign="top">June 30, </td><td style="width:13.5pt" valign="top"> </td><td colspan="3" style="width:141.55pt" valign="top">June 30, </td></tr> <tr style="height:12.5pt"><td style="width:133.85pt" valign="top"></td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">2026 </td><td style="width:13.5pt" valign="top"> </td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">2025 </td><td style="width:13.5pt" valign="top"> </td><td style="width:60.55pt;border-bottom:0.5pt solid #000000" valign="middle">2026 </td><td style="width:13.5pt" valign="top"> </td><td style="width:67.5pt;border-bottom:0.5pt solid #000000" valign="middle">2025 </td></tr> <tr style="height:12.5pt"><td style="background-color:#D3F0FE;width:133.85pt" valign="top">Numerator </td><td style="background-color:#D3F0FE;width:63pt;border-top:0.5pt solid #000000" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt;border-top:0.5pt solid #000000" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:60.55pt;border-top:0.5pt solid #000000" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:67.5pt;border-top:0.5pt solid #000000" valign="top"> </td></tr> <tr style="height:11.2pt"><td style="width:133.85pt" valign="top">Net income </td><td style="width:63pt" valign="middle">2,686 </td><td style="width:13.5pt" valign="top"> </td><td style="width:63pt" valign="middle">3,048 </td><td style="width:13.5pt" valign="top"> </td><td style="width:60.55pt" valign="middle">5,290 </td><td style="width:13.5pt" valign="top"> </td><td style="width:67.5pt" valign="middle">6,089 </td></tr> <tr style="height:12.5pt"><td style="background-color:#D3F0FE;width:133.85pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:60.55pt" valign="top"> </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:67.5pt" valign="top"> </td></tr> <tr style="height:12pt"><td style="width:133.85pt" valign="top">Denominator </td><td style="width:63pt" valign="top"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:63pt" valign="top"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:60.55pt" valign="top"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:67.5pt" valign="top"> </td></tr> <tr style="height:12.5pt"><td style="background-color:#D3F0FE;width:133.85pt" valign="top">Weighted average shares, basic </td><td style="background-color:#D3F0FE;width:63pt" valign="middle">3,184 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt" valign="middle">3,246 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:60.55pt" valign="middle">3,184 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:67.5pt" valign="middle">3,278 </td></tr> <tr style="height:12.5pt"><td style="width:133.85pt" valign="top">Dilutive effect of stock options </td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">- </td><td style="width:13.5pt" valign="top"> </td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">- </td><td style="width:13.5pt" valign="top"> </td><td style="width:60.55pt;border-bottom:0.5pt solid #000000" valign="middle">- </td><td style="width:13.5pt" valign="top"> </td><td style="width:67.5pt;border-bottom:0.5pt solid #000000" valign="middle">- </td></tr> <tr style="height:12.5pt"><td style="background-color:#D3F0FE;width:133.85pt" valign="top">Diluted shares </td><td style="background-color:#D3F0FE;width:63pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle">3,184 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle">3,246 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:60.55pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle">3,184 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:67.5pt;border-top:0.5pt solid #000000;border-bottom:3px double #000000" valign="middle">3,278 </td></tr> <tr style="height:12.5pt"><td style="width:133.85pt" valign="top"> </td><td style="width:63pt;border-top:3px double #000000" valign="middle"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:63pt;border-top:3px double #000000" valign="middle"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:60.55pt;border-top:3px double #000000" valign="middle"> </td><td style="width:13.5pt" valign="top"> </td><td style="width:67.5pt;border-top:3px double #000000" valign="middle"> </td></tr> <tr style="height:12.5pt"><td style="background-color:#D3F0FE;width:133.85pt" valign="top">Earnings per share, basic </td><td style="background-color:#D3F0FE;width:63pt" valign="middle">0.84 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:63pt" valign="middle">0.94 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:60.55pt" valign="middle">1.66 </td><td style="background-color:#D3F0FE;width:13.5pt" valign="top"> </td><td style="background-color:#D3F0FE;width:67.5pt" valign="middle">1.86 </td></tr> <tr style="height:12.5pt"><td style="width:133.85pt;border-bottom:0.5pt solid #000000" valign="top">Earnings per share, diluted </td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">0.84 </td><td style="width:13.5pt;border-bottom:0.5pt solid #000000" valign="top"> </td><td style="width:63pt;border-bottom:0.5pt solid #000000" valign="middle">0.94 </td><td style="width:13.5pt;border-bottom:0.5pt solid #000000" valign="top"> </td><td style="width:60.55pt;border-bottom:0.5pt solid #000000" valign="middle">1.66 </td><td style="width:13.5pt;border-bottom:0.5pt solid #000000" valign="top"> </td><td style="width:67.5pt;border-bottom:0.5pt solid #000000" valign="middle">1.86 </td></tr> </table>

2686000

3048000

5290000

6089000

3184000

3246000

3184000

3278000

3184000

3246000

3184000

3278000

0.84

0.94

1.66

1.86

0.84

0.94

1.66

1.86

8) Segment Information. The Company operates as one operating segment. The Company’s chief operating decision maker (“CODM”) is its chief executive officer, who reviews financial information presented on a consolidated basis. The CODM uses consolidated gross profit margin, operating margin, and net income to assess financial performance and allocate resources. These financial metrics are used by the CODM to make key operating decisions such as the allocation of budget between cost of sales, sales and marketing, research and development, and general and administrative expenses. The following table presents selected financial information with respect to the Company’s single operating segment for the quarters ended June 30, 2026 and June 30, 2025: <table style="border-collapse:collapse;width:288.9pt"><tr style="height:7.2pt"><td valign="top"> </td><td colspan="3" style="width:129.35pt" valign="top">Quarter Ended June 30, </td></tr> <tr style="height:7.2pt"><td valign="top"></td><td style="width:60.3pt;border-bottom:0.5pt solid #000000" valign="top">2026 </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt;border-bottom:0.5pt solid #000000" valign="top">2025 </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Revenues </td><td style="background-color:#D3F0FE;width:60.3pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">8,529 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">9,953 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Less: </td><td style="width:60.3pt" valign="top"> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt" valign="top"> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Standard cost of sales </td><td style="background-color:#D3F0FE;width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">3,175 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">3,763 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Other cost of sales </td><td style="width:60.3pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">596 </kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">595 </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Gross Profit </td><td style="background-color:#D3F0FE;width:60.3pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">4,758 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">5,595 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Gross Profit Margin </td><td style="width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">55.8%</kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">56.2%</kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Sales & Marketing </td><td style="background-color:#D3F0FE;width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">526 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">525 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Research & Development </td><td style="width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">154 </kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">135 </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Litigation Fees </td><td style="background-color:#D3F0FE;width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">498 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">284 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Amortization </td><td style="width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">16 </kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">540 </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Other General & Administrative </td><td style="background-color:#D3F0FE;width:60.3pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">915 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">915 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Operating Income </td><td style="width:60.3pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">2,649 </kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">3,196 </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Operating Income Margin </td><td style="background-color:#D3F0FE;width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">31.1%</kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">32.1%</kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Other Income </td><td style="width:60.3pt" valign="top"> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt" valign="top"> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Interest income </td><td style="background-color:#D3F0FE;width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">635 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">679 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Other income (expense) </td><td style="width:60.3pt;border-bottom:0.5pt solid #000000" valign="top"> 2 </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">(40) </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Income before income taxes </td><td style="background-color:#D3F0FE;width:60.3pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">3,286 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">3,835 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Provision for income taxes </td><td style="width:60.3pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">600 </kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">787 </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Net Income </td><td style="background-color:#D3F0FE;width:60.3pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">2,686 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">3,048 </kbd> </td></tr> </table>

<table style="border-collapse:collapse;width:288.9pt"><tr style="height:7.2pt"><td valign="top"> </td><td colspan="3" style="width:129.35pt" valign="top">Quarter Ended June 30, </td></tr> <tr style="height:7.2pt"><td valign="top"></td><td style="width:60.3pt;border-bottom:0.5pt solid #000000" valign="top">2026 </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt;border-bottom:0.5pt solid #000000" valign="top">2025 </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Revenues </td><td style="background-color:#D3F0FE;width:60.3pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">8,529 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">9,953 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Less: </td><td style="width:60.3pt" valign="top"> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt" valign="top"> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Standard cost of sales </td><td style="background-color:#D3F0FE;width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">3,175 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">3,763 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Other cost of sales </td><td style="width:60.3pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">596 </kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">595 </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Gross Profit </td><td style="background-color:#D3F0FE;width:60.3pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">4,758 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">5,595 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Gross Profit Margin </td><td style="width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">55.8%</kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">56.2%</kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Sales & Marketing </td><td style="background-color:#D3F0FE;width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">526 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">525 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Research & Development </td><td style="width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">154 </kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">135 </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Litigation Fees </td><td style="background-color:#D3F0FE;width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">498 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">284 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Amortization </td><td style="width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">16 </kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">540 </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Other General & Administrative </td><td style="background-color:#D3F0FE;width:60.3pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">915 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">915 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Operating Income </td><td style="width:60.3pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">2,649 </kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">3,196 </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Operating Income Margin </td><td style="background-color:#D3F0FE;width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">31.1%</kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">32.1%</kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Other Income </td><td style="width:60.3pt" valign="top"> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt" valign="top"> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Interest income </td><td style="background-color:#D3F0FE;width:60.3pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">635 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">679 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Other income (expense) </td><td style="width:60.3pt;border-bottom:0.5pt solid #000000" valign="top"> 2 </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">(40) </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Income before income taxes </td><td style="background-color:#D3F0FE;width:60.3pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">3,286 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">3,835 </kbd> </td></tr> <tr style="height:7.2pt"><td valign="top">Provision for income taxes </td><td style="width:60.3pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">600 </kbd> </td><td style="width:11.8pt" valign="top"> </td><td style="width:57.25pt;border-bottom:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">787 </kbd> </td></tr> <tr style="height:7.2pt"><td style="background-color:#D3F0FE" valign="top">Net Income </td><td style="background-color:#D3F0FE;width:60.3pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:42pt">2,686 </kbd> </td><td style="background-color:#D3F0FE;width:11.8pt" valign="top"> </td><td style="background-color:#D3F0FE;width:57.25pt;border-top:0.5pt solid #000000" valign="top"><kbd style="position:absolute;text-align:right;font:10pt Times New Roman;width:43pt">3,048 </kbd> </td></tr> </table>

8529000

9953000

3175000 3763000 596000 595000

4758000

5595000

0.558 0.562

526000

525000

154000

135000

498000 284000

16000

540000

915000

2649000

3196000

0.311 0.321

635000

679000

2000

-40000

3286000

3835000

600000

787000

2686000

3048000

<kbd style="position:absolute;font:10pt Times New Roman;margin-left:0pt">(9)</kbd><kbd style="margin-left:18pt"></kbd> Subsequent Events. UTMD has evaluated subsequent events through the date the financial statements were issued, and concluded there were no other events or transactions during this period that required recognition or disclosure in its June 30, 2026 financial statements.